Results 191 to 200 of about 322,252 (278)
Rethinking hospitalisations for substance use disorders
Daniele Zullino
doaj +1 more source
The Role of Psychedelics in the Treatment of Substance Use Disorders: An Overview of Systematic Reviews. [PDF]
Correa da Costa S +7 more
europepmc +1 more source
Editorial: Impulsivity and compulsivity related to substance use disorders [PDF]
Francisca López-Torrecillas
openalex +1 more source
ABSTRACT Mutations in myelin regulatory factor (MYRF) are linked to demyelinating disorders. We report a 38‐year‐old male who developed acute symmetric leukoencephalopathy mimicking a stroke following an influenza A virus infection. While clinical symptoms markedly improved with corticosteroids, MRI revealed persistent white matter lesions, contrasting
Jinghan Hu +5 more
wiley +1 more source
Impact of a Preclinical Elective on Medical Student Attitudes Toward People With Substance Use Disorders. [PDF]
Cooper C +5 more
europepmc +1 more source
ABSTRACT Objective Plasma fibrinogen is essential in thrombosis and fibrinolysis, yet its dynamic changes pre‐ and post‐intravenous thrombolysis (IVT) for predicting brain injury severity and prognosis in acute ischemic stroke (AIS) patients remain unclear.
Wenhai Zhai +28 more
wiley +1 more source
Ethical Dilemmas and Approaches to Acute Pain Management in Patients With Substance Use Disorders. [PDF]
Virno T, Van Rensburg C, Ballantyne M.
europepmc +1 more source
ABSTRACT Pathogenic variants in KIF1C cause Spastic Paraplegia 58 (SPG58), typically presenting with cerebellar ataxia and spastic paraparesis. We report two unrelated patients with spastic paraparesis, cerebellar ataxia, and tremor. Whole‐exome sequence analysis identified novel homozygous variants in the motor domain of KIF1C (NM_006612.6): c.921G>A (
Akihiko Mitsutake +12 more
wiley +1 more source

